139 related articles for article (PubMed ID: 12906929)
41. C5a-induced hemodynamic and hematologic changes in the rabbit. Role of cyclooxygenase products and polymorphonuclear leukocytes.
Lundberg C; Marceau F; Hugli TE
Am J Pathol; 1987 Sep; 128(3):471-83. PubMed ID: 3115110
[TBL] [Abstract][Full Text] [Related]
42. Glycogenolytic effect of adenosine involves ATP from hepatocytes and eicosanoids from Kupffer cells.
Nukina S; Fusaoka T; Thurman RG
Am J Physiol; 1994 Jan; 266(1 Pt 1):G99-105. PubMed ID: 8304463
[TBL] [Abstract][Full Text] [Related]
43. Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers.
Abe Y; Aly HH; Hiraga N; Imamura M; Wakita T; Shimotohno K; Chayama K; Hijikata M
Gastroenterology; 2013 Sep; 145(3):658-67.e11. PubMed ID: 23684750
[TBL] [Abstract][Full Text] [Related]
44. Studies on synthesis and degradation of eicosanoids by rat hepatocytes in primary culture.
Tran-Thi TA; Gyufko K; Henninger H; Busse R; Decker K
J Hepatol; 1987 Dec; 5(3):322-31. PubMed ID: 2828463
[TBL] [Abstract][Full Text] [Related]
45. Effect of furegrelate on renal plasma flow after angiotensin II infusion.
Kaushal RD; Wilson TW
Can J Physiol Pharmacol; 1990 Apr; 68(4):500-4. PubMed ID: 2328452
[TBL] [Abstract][Full Text] [Related]
46. Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.
Schlaf G; Schieferdecker HL; Rothermel E; Jungermann K; Götze O
Lab Invest; 1999 Oct; 79(10):1287-97. PubMed ID: 10532591
[TBL] [Abstract][Full Text] [Related]
47. Effect of ifetroban, a thromboxane A2 receptor antagonist, in stroke-prone spontaneously hypertensive rats.
Johnson RA; Belmonte A; Fan NY; Lavesa M; Nasjletti A; Stier CT
Clin Exp Hypertens; 1996 Feb; 18(2):171-88. PubMed ID: 8868999
[TBL] [Abstract][Full Text] [Related]
48. Induction by interleukin 6 of G(s)-coupled prostaglandin E(2) receptors in rat hepatocytes mediating a prostaglandin E(2)-dependent inhibition of the hepatocyte's acute phase response.
Fennekohl A; Lucas M; Püschel GP
Hepatology; 2000 May; 31(5):1128-34. PubMed ID: 10796889
[TBL] [Abstract][Full Text] [Related]
49. Functional coupling of cyclooxygenase 1 and 2 to discrete prostanoid synthases in liver macrophages.
Dieter P; Scheibe R; Jakobsson PJ; Watanabe K; Kolada A; Kamionka S
Biochem Biophys Res Commun; 2000 Sep; 276(2):488-92. PubMed ID: 11027502
[TBL] [Abstract][Full Text] [Related]
50. Failure of aspirin to interfere with the cardioprotective effects of ifetroban.
Gomoll AW; Ogletree ML
Eur J Pharmacol; 1994 Dec; 271(2-3):471-9. PubMed ID: 7705447
[TBL] [Abstract][Full Text] [Related]
51. Daltroban blocks thromboxane responses in the pulmonary vascular bed of the cat.
Hood JS; Nossaman BD; Ibrahim IN; McMahon TJ; Babycos CR; Kadowitz PJ
J Appl Physiol (1985); 1992 Jun; 72(6):2305-10. PubMed ID: 1385804
[TBL] [Abstract][Full Text] [Related]
52. Cytoprotection by the osmolytes betaine and taurine in ischemia-reoxygenation injury in the perfused rat liver.
Wettstein M; Häussinger D
Hepatology; 1997 Dec; 26(6):1560-6. PubMed ID: 9397998
[TBL] [Abstract][Full Text] [Related]
53. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
54. Impaired renal function in obstructive jaundice: enhanced glomerular thromboxane synthesis and effects of thromboxane receptor blockade in bile duct-ligated rats.
Kramer HJ; Schwarting K; Bäcker A
Clin Sci (Lond); 1995 Jan; 88(1):39-45. PubMed ID: 7704998
[TBL] [Abstract][Full Text] [Related]
55. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages.
Matsumoto H; Naraba H; Murakami M; Kudo I; Yamaki K; Ueno A; Oh-ishi S
Biochem Biophys Res Commun; 1997 Jan; 230(1):110-4. PubMed ID: 9020023
[TBL] [Abstract][Full Text] [Related]
56. Hydroperoxide metabolism in rat liver. K+ channel activation, cell volume changes and eicosanoid formation.
Hallbrucker C; Ritter M; Lang F; Gerok W; Häussinger D
Eur J Biochem; 1993 Feb; 211(3):449-58. PubMed ID: 8436107
[TBL] [Abstract][Full Text] [Related]
57. Cyclosporine-induced coronary artery constriction--dissociation between thromboxane release and coronary vasospasm.
Braun-Dullaeus RC; Feussner M; Walker G; Hopmann H; Kraemer HJ; Grimminger F; Tillmanns H; Haberbosch W
J Heart Lung Transplant; 1999 Apr; 18(4):328-35. PubMed ID: 10226897
[TBL] [Abstract][Full Text] [Related]
58. Effects of daltroban, a thromboxane (TX) A2 receptor antagonist, on lipid metabolism and atherosclerosis.
Pill J; Metz J; Stegmeier K; Hartig F
Agents Actions Suppl; 1992; 37():107-13. PubMed ID: 1632287
[TBL] [Abstract][Full Text] [Related]
59. Effect of PGI2 and thromboxane antagonist on liver ischemic injury.
Besse T; Gustin T; Claeys N; Schroeyers P; Lambotte L
Eur Surg Res; 1989; 21(3-4):213-7. PubMed ID: 2478369
[TBL] [Abstract][Full Text] [Related]
60. Antiplatelet effect of a new inhibitor of thromboxane synthase and thromboxane A2 receptors.
Tubaro E; Belogi L; Mezzadri CM
Arzneimittelforschung; 1996 Jan; 46(1):35-41. PubMed ID: 8821515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
